Literature DB >> 18697508

Restless legs syndrome.

Max Bayard1, Thomas Avonda, James Wadzinski.   

Abstract

Restless legs syndrome is a common neurologic movement disorder that affects approximately 10 percent of adults. Of those affected with this condition, approximately one third have symptoms severe enough to require medical therapy. Restless legs syndrome may be a primary condition, or it may be secondary to iron deficiency, renal failure, pregnancy, or the use of certain medications. The diagnosis is clinical, requiring an urge to move the legs usually accompanied by an uncomfortable sensation, occurrence at rest, improvement with activity, and worsening of symptoms in the evening or at night. Restless legs syndrome causes sleep disturbances, is associated with anxiety and depression, and has a negative effect on quality of life. Treatment of secondary causes of restless legs syndrome may result in improvement or resolution of symptoms. Currently, there is little information regarding the effects of lifestyle changes on the symptoms of restless legs syndrome. If medications are needed, dopamine agonists are the primary medications for moderate to severe restless legs syndrome. Other medications that may be effective include gabapentin, carbidopa/levodopa, opioids, and benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18697508

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  13 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Restless legs syndrome due to aripiprazole.

Authors:  Juan Bolaños-Vergaray; Juan Carlos Obaya; Rafael Gonzalez; Cristina Echeverri; Pilar Piquer
Journal:  Eur J Clin Pharmacol       Date:  2010-11-21       Impact factor: 2.953

3.  Alleviation of severe restless legs syndrome (RLS) symptoms by cigarette smoking.

Authors:  Arie Oksenberg
Journal:  J Clin Sleep Med       Date:  2010-10-15       Impact factor: 4.062

4.  Accompanying migrainous features in pediatric migraine patients with restless legs syndrome.

Authors:  Melis Sohtaoğlu Sevindik; Seden Demirci; Baki Göksan; Aynur Özge; Feray Karaali Savrun; Hatice Onur; Veli Yıldırım; Ismail Simsek; Harika Ozhan; Derya Uludüz
Journal:  Neurol Sci       Date:  2017-07-01       Impact factor: 3.307

5.  The higher prevalence of non-right handers among patients with restless leg syndrome.

Authors:  Shadi Ghourchian; Parviz Bahrami
Journal:  Neurol Sci       Date:  2014-07-02       Impact factor: 3.307

6.  Restless legs syndrome in hemodialysis patients in Iran.

Authors:  Mohammad Rohani; Mahbubeh Aghaei; Arya Jenabi; Sharare Yazdanfar; Delaram Mousavi; Shahnaz Miri
Journal:  Neurol Sci       Date:  2014-12-05       Impact factor: 3.307

7.  Prevalence of restless legs syndrome in pregnant women in Oman and its effect on pregnancy and neonatal outcomes.

Authors:  Asma S Al Shidhani; Naama A Al Rawahi; Zuwaina K Al Yahiyai; Imrana Masood; Zainab A Al Saadi; Samah S Al Shukaili; Sayed G Rizvi; Sachin Jose
Journal:  J Family Community Med       Date:  2022-05-13

8.  The effect of selenium administration on restless leg syndrome treatment.

Authors:  A G Rahimdel; P Ayatollahi; A Zeinali; N Mehrabanian; A Mellat-Ardekani
Journal:  Iran Red Crescent Med J       Date:  2012-01-01       Impact factor: 0.611

9.  Prevalence of restless legs syndrome and associated risk factors among middle-aged Saudi population.

Authors:  Siraj Omar Wali; Bahaa Abaalkhail
Journal:  Ann Thorac Med       Date:  2015 Jul-Sep       Impact factor: 2.219

10.  The effects of two methods of reflexology and stretching exercises on the severity of restless leg syndrome among hemodialysis patients.

Authors:  Nahid Shahgholian; Shahrzad Khojandi Jazi; Jahangir Karimian; Mahboubeh Valiani
Journal:  Iran J Nurs Midwifery Res       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.